Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use.

Saved in:
Bibliographic Details
Title: Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use.
Authors: Pytell JD; Division of General Internal Medicine, Department of Medicine, University of Colorado School of Medicine, Mail Stop B180, 12631 E. 17Th Ave, Aurora, CO, 80045, USA. Jarratt.Pytell@cuanschutz.edu., Fojo AT; Division of General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA., Keruly JC; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Snow LN; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Falade-Nwulia O; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Moore RD; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Chander G; Division of General Internal Medicine, University of Washington School of Medicine, Seattle, WA, USA., Lesko CR; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Source: Addiction science & clinical practice [Addict Sci Clin Pract] 2023 Sep 02; Vol. 18 (1), pp. 51. Date of Electronic Publication: 2023 Sep 02.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101316917 Publication Model: Electronic Cited Medium: Internet ISSN: 1940-0640 (Electronic) Linking ISSN: 19400632 NLM ISO Abbreviation: Addict Sci Clin Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1940-0640
DOI:10.1186/s13722-023-00408-8